Scarica l'app Stockscreener
4.86
25.91%
1.00
Dopo l'orario di chiusura:
4.70
-0.16
-3.29%
Precedente Chiudi:
$3.86
Aprire:
$4.2
Volume 24 ore:
5.61M
Relative Volume:
6.72
Capitalizzazione di mercato:
$360.92M
Reddito:
$6.96M
Utile/perdita netta:
$-46.51M
Rapporto P/E:
-28.32
EPS:
-0.1716
Flusso di cassa netto:
$-37.99M
1 W Prestazione:
+33.52%
1M Prestazione:
+50.46%
6M Prestazione:
+161.29%
1 anno Prestazione:
-63.32%
Intervallo 1D:
$4.08
$5.30
Intervallo di 1 settimana:
$3.37
$5.30
Portata 52W:
$1.60
$13.19
Perspective Therapeutics Inc Stock (CATX) Company Profile
Nome
Perspective Therapeutics Inc
Settore
Industria
Telefono
509-375-1202
Indirizzo
350 Hills Street, Suite 106, Richland
Confronta CATX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
4.86 | 286.66M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-11-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-01 | Iniziato | Wedbush | Outperform |
| 2024-09-25 | Iniziato | Truist | Buy |
| 2024-07-25 | Iniziato | BofA Securities | Buy |
| 2024-05-09 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Perspective Therapeutics Inc Borsa (CATX) Ultime notizie
Using Bollinger Bands to evaluate Perspective Therapeutics Inc.Oil Prices & Consistent Growth Equity Picks - newser.com
Can Perspective Therapeutics Inc. rally from current levelsJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Has Perspective Therapeutics Inc. found a price floor2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Will Perspective Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
BTIG initiates coverage on Perspective Therapeutics stock with Buy rating By Investing.com - Investing.com Nigeria
BTIG Research Initiates Coverage on Perspective Therapeutics With Buy Rating, $14 Price Target - MarketScreener
BTIG initiates coverage on Perspective Therapeutics stock with Buy rating - Investing.com India
BTIG Initiates Coverage on CATX with a Buy Rating and $14 Target | CATX Stock News - GuruFocus
Perspective Therapeutics Inc. stock momentum explainedWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
Technical analysis overview for Perspective Therapeutics Inc. stock - newser.com
Will Perspective Therapeutics Inc. stock outperform small cap peers2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
Real time social sentiment graph for Perspective Therapeutics Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
How robust is Perspective Therapeutics Inc. stock financial positionJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Why Perspective Therapeutics Inc. (AAJ0) stock stays undervaluedTrade Signal Summary & Long-Term Safe Investment Plans - newser.com
How dovish Fed policy supports Perspective Therapeutics Inc. (AAJ0) stock2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Will Perspective Therapeutics Inc. rebound enough to break evenWeekly Gains Summary & High Conviction Trade Alerts - newser.com
Candlestick signals on Perspective Therapeutics Inc. stock todayTreasury Yields & AI Powered Market Entry Strategies - newser.com
Volatility clustering patterns for Perspective Therapeutics Inc.Portfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
Will Perspective Therapeutics Inc. stock go up soonMarket Sentiment Review & Safe Capital Growth Stock Tips - newser.com
Top chart patterns to watch in Perspective Therapeutics Inc.2025 Market Trends & Verified Entry Point Signals - newser.com
Perspective Therapeutics Inc. stock outlook for YEARMarket Trend Summary & Daily Technical Forecast Reports - newser.com
Can Perspective Therapeutics Inc. stock reach $200 price target2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Analyzing Perspective Therapeutics Inc. with risk reward ratio charts2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Applying Elliott Wave Theory to Perspective Therapeutics Inc.Gap Up & Free Fast Entry Momentum Trade Alerts - newser.com
What drives Perspective Therapeutics Inc AAJ0 stock priceMoving Average Crossovers & Free Record-Breaking Gains - earlytimes.in
Perspective Therapeutics, Inc. Common Stock (NYSE:CATX) Stock Quote - FinancialContent
How Perspective Therapeutics Inc. (AAJ0) stock valuation compares with sectorMarket Activity Report & Safe Entry Momentum Tips - newser.com
Heatmap analysis for Perspective Therapeutics Inc. and competitorsTrend Reversal & Safe Entry Momentum Tips - newser.com
Is Perspective Therapeutics Inc. (AAJ0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - newser.com
Is Perspective Therapeutics Inc. stock attractive for retirement portfoliosWeekly Stock Recap & Consistent Growth Equity Picks - newser.com
Is Perspective Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
What earnings revisions data tells us about Perspective Therapeutics Inc.July 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
Perspective Therapeutics (NYSE:CATX) Receives Outperform Rating from Wedbush - Defense World
Perspective Therapeutics (NYSE:CATX) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reiterates Buy Rating for Perspective Therapeutics (NYSE:CATX) - MarketBeat
CATX: HC Wainwright & Co. Reiterates Buy Rating with $10 Target - GuruFocus
HC Wainwright & Co. Reiterates Perspective Therapeutics (CATX) Buy Recommendation - Nasdaq
H.C. Wainwright reiterates Buy rating on Perspective Therapeutics stock - Investing.com
Why Perspective Therapeutics Inc. (AAJ0) stock is favored by hedge fundsEarnings Risk Report & Precise Trade Entry Recommendations - newser.com
Is Perspective Therapeutics Inc. stock ready for a breakoutMarket Activity Summary & AI Driven Stock Price Forecasts - newser.com
Perspective Therapeutics Announces First Patient Dosed with - GlobeNewswire
Can Perspective Therapeutics Inc. stock sustain margin levelsWeekly Trading Summary & Expert Verified Movement Alerts - newser.com
Can Perspective Therapeutics Inc. (AAJ0) stock sustain free cash flowJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Long term hold vs stop loss in Perspective Therapeutics Inc.Market Risk Analysis & Growth Focused Entry Reports - newser.com
What macro factors could drive Perspective Therapeutics Inc. (AAJ0) stock higherEntry Point & High Return Trade Guides - newser.com
Sector ETF performance correlation with Perspective Therapeutics Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - newser.com
Perspective Therapeutics Inc Azioni (CATX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Capitalizzazione:
|
Volume (24 ore):